DarioHealth Financial Statements From 2010 to 2024

DRIO Stock  USD 0.72  0.05  7.46%   
DarioHealth Corp financial statements provide useful quarterly and yearly information to potential DarioHealth Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on DarioHealth Corp financial statements helps investors assess DarioHealth Corp's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting DarioHealth Corp's valuation are summarized below:
Gross Profit
14 M
Profit Margin
(2.06)
Market Capitalization
24.6 M
Enterprise Value Revenue
1.7133
Revenue
23.1 M
We have found one hundred twenty available fundamental signals for DarioHealth Corp, which can be analyzed and compared to other ratios and to its rivals. Self-guided Investors are advised to verify DarioHealth Corp's prevailing fundamentals against the trend between 2010 and 2024 to make sure the company can sustain itself down the road. As of the 29th of November 2024, Market Cap is likely to drop to about 37 M. In addition to that, Enterprise Value is likely to drop to about 27.6 M

DarioHealth Corp Total Revenue

21.37 Million

Check DarioHealth Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among DarioHealth Corp's main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.2 M, Interest Expense of 677.2 K or Selling General Administrative of 9.6 M, as well as many indicators such as Price To Sales Ratio of 2.28, Dividend Yield of 0.0 or PTB Ratio of 0.71. DarioHealth financial statements analysis is a perfect complement when working with DarioHealth Corp Valuation or Volatility modules.
  
Check out the analysis of DarioHealth Corp Correlation against competitors.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.

DarioHealth Corp Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets101.2 M96.4 M34.8 M
Slightly volatile
Other Current Liabilities6.5 M6.2 M2.6 M
Slightly volatile
Total Current Liabilities6.9 M12.5 M5.5 M
Slightly volatile
Property Plant And Equipment Net1.2 M1.9 M1.1 M
Slightly volatile
Accounts PayableM1.1 M1.6 M
Slightly volatile
Cash38.6 M36.8 M15.7 M
Slightly volatile
Non Current Assets Total51.8 M49.3 M14.7 M
Slightly volatile
Non Currrent Assets Other406.4 K387 K114.4 K
Slightly volatile
Cash And Short Term Investments38.6 M36.8 M15.8 M
Slightly volatile
Net Receivables3.8 M3.6 M1.3 M
Slightly volatile
Common Stock Total Equity4.5 K3.5 K3.4 K
Pretty Stable
Common Stock Shares Outstanding29.8 M28.4 M7.2 M
Slightly volatile
Short Term Investments174.9 K335.8 K189 K
Slightly volatile
Liabilities And Stockholders Equity101.2 M96.4 M34.8 M
Slightly volatile
Other Current AssetsM1.8 M841.4 K
Slightly volatile
Other Stockholder Equity427.9 M407.5 M142.7 M
Slightly volatile
Total Liabilities40.2 M38.2 M12.6 M
Slightly volatile
Property Plant And Equipment Gross3.5 M3.4 M1.5 M
Slightly volatile
Total Current Assets49.7 M47.3 M20.1 M
Slightly volatile
Common Stock4.3 K3.5 K3.4 K
Pretty Stable
Other Liabilities778 K819 KM
Slightly volatile
Capital Surpluse441.8 M420.7 M147.3 M
Slightly volatile
Property Plant Equipment708.3 K709.2 K913.7 K
Slightly volatile
Short and Long Term Debt Total31 M29.5 M7.2 M
Slightly volatile
WarrantsM2.1 M2.5 M
Slightly volatile
Current Deferred Revenue928.1 K997 K616.4 K
Slightly volatile
InventoryM5.1 M2.1 M
Slightly volatile
Deferred Long Term Liabilities778 K819 K2.4 M
Slightly volatile
Preferred Stock Total EquityM2.1 M2.5 M
Slightly volatile
Long Term Debt16.5 M24.6 M12.1 M
Slightly volatile
Long Term Debt Total11.3 M20.8 M11.5 M
Slightly volatile
Net Invested Capital53.3 M86.7 M28 M
Slightly volatile
Net Working Capital26.4 M34.8 M14.4 M
Slightly volatile
Capital Lease Obligations815.5 K996 K764.7 K
Very volatile
Short Term Debt3.2 M4.2 M1.4 M
Slightly volatile
Non Current Liabilities Other34.2 K36 K736.6 K
Slightly volatile
Intangible Assets7.4 M5.4 M11.5 M
Slightly volatile
Short and Long Term Debt5.1 MM8.3 M
Slightly volatile

DarioHealth Corp Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization5.2 MM1.4 M
Slightly volatile
Selling General Administrative9.6 M18.1 M7.9 M
Slightly volatile
Selling And Marketing Expenses13.6 M23.8 M10.8 M
Slightly volatile
Other Operating Expenses80.4 M76.5 M33.6 M
Slightly volatile
Research Development21.3 M20.2 M7.4 M
Slightly volatile
Total Operating Expenses31.2 M62.2 M25.3 M
Slightly volatile
Cost Of Revenue8.9 M14.4 M9.3 M
Very volatile
Preferred Stock And Other Adjustments226.6 K238.5 K1.1 M
Slightly volatile
Interest Income1.8 M1.7 M613.6 K
Pretty Stable
Reconciled Depreciation5.2 M4.9 M1.3 M
Slightly volatile

DarioHealth Corp Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation20.7 M19.7 M7.7 M
Slightly volatile
Begin Period Cash Flow51.9 M49.5 M14.2 M
Slightly volatile
Depreciation5.2 MM1.4 M
Slightly volatile
Capital Expenditures354.4 K584 K449.3 K
Slightly volatile
Total Cash From Financing Activities24.6 M18.3 M20.1 M
Slightly volatile
End Period Cash Flow38.6 M36.8 M15.7 M
Slightly volatile
Change To Netincome20.5 M19.5 M7.1 M
Slightly volatile
Issuance Of Capital Stock15.9 M16.7 M23.8 M
Slightly volatile
Net Borrowings19 M21.4 M23.3 M
Slightly volatile
Dividends Paid19 M21.4 M23.3 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.282.397814.9579
Slightly volatile
Days Sales Outstanding68.261.0665109
Slightly volatile
Stock Based Compensation To Revenue0.920.96811.6718
Slightly volatile
Capex To Depreciation0.110.11724.8892
Slightly volatile
Inventory Turnover4.082.83845.3382
Slightly volatile
Days Of Inventory On Hand93.012993.716
Slightly volatile
Payables Turnover13.3412.70389.7136
Slightly volatile
Sales General And Administrative To Revenue0.850.891324.6132
Slightly volatile
Research And Ddevelopement To Revenue0.950.994926.4105
Slightly volatile
Capex To Revenue0.02730.02873.7189
Slightly volatile
Cash Per Share1.231.296947.4736
Slightly volatile
Days Payables Outstanding27.2928.731696.3014
Pretty Stable
Income Quality0.540.51120.6479
Pretty Stable
Intangibles To Total Assets0.540.48810.5269
Slightly volatile
Current Ratio2.263.78852.8011
Slightly volatile
Receivables Turnover5.685.97719.3867
Pretty Stable
Graham Number9.349.8276355
Slightly volatile
Debt To Equity0.520.49280.1021
Slightly volatile
Capex Per Share0.01960.020620.6988
Slightly volatile
Revenue Per Share0.680.71733.6994
Pretty Stable
Interest Debt Per Share1.831.03272.326
Slightly volatile
Debt To Assets0.310.29730.0649
Slightly volatile
Operating Cycle143190201
Slightly volatile
Days Of Payables Outstanding27.2928.731696.3014
Pretty Stable
Ebt Per Ebit1.171.05651.1181
Slightly volatile
Long Term Debt To Capitalization0.190.29720.1924
Slightly volatile
Total Debt To Capitalization0.350.33010.0741
Slightly volatile
Debt Equity Ratio0.520.49280.1021
Slightly volatile
Quick Ratio2.043.38332.5658
Pretty Stable
Net Income Per E B T0.81.00110.9869
Slightly volatile
Cash Ratio1.722.94542.1272
Slightly volatile
Days Of Inventory Outstanding93.012993.716
Slightly volatile
Days Of Sales Outstanding68.261.0665109
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.161.01921.0757
Slightly volatile
Fixed Asset Turnover6.2610.90685.6459
Slightly volatile
Debt Ratio0.310.29730.0649
Slightly volatile
Price Sales Ratio2.282.397814.9579
Slightly volatile
Asset Turnover0.360.21110.251
Slightly volatile

DarioHealth Corp Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap37 M48.8 M37.5 M
Slightly volatile

DarioHealth Fundamental Market Drivers

Cash And Short Term Investments36.8 M

DarioHealth Upcoming Events

14th of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About DarioHealth Corp Financial Statements

DarioHealth Corp investors utilize fundamental indicators, such as revenue or net income, to predict how DarioHealth Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue997 K928.1 K
Total Revenue20.4 M21.4 M
Cost Of Revenue14.4 M8.9 M
Stock Based Compensation To Revenue 0.97  0.92 
Sales General And Administrative To Revenue 0.89  0.85 
Research And Ddevelopement To Revenue 0.99  0.95 
Capex To Revenue 0.03  0.03 
Revenue Per Share 0.72  0.68 
Ebit Per Revenue(2.76)(2.90)

Pair Trading with DarioHealth Corp

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if DarioHealth Corp position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in DarioHealth Corp will appreciate offsetting losses from the drop in the long position's value.

Moving against DarioHealth Stock

  0.73GH Guardant HealthPairCorr
  0.64LH LaboratoryPairCorr
  0.57DXCM DexCom IncPairCorr
  0.49VREX Varex Imaging CorpPairCorr
  0.43VEEV Veeva Systems Class Earnings Call This WeekPairCorr
The ability to find closely correlated positions to DarioHealth Corp could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace DarioHealth Corp when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back DarioHealth Corp - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling DarioHealth Corp to buy it.
The correlation of DarioHealth Corp is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as DarioHealth Corp moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if DarioHealth Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for DarioHealth Corp can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether DarioHealth Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DarioHealth Corp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dariohealth Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dariohealth Corp Stock:
Check out the analysis of DarioHealth Corp Correlation against competitors.
To learn how to invest in DarioHealth Stock, please use our How to Invest in DarioHealth Corp guide.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DarioHealth Corp. If investors know DarioHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DarioHealth Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.93)
Revenue Per Share
0.631
Quarterly Revenue Growth
1.11
Return On Assets
(0.35)
Return On Equity
(0.75)
The market value of DarioHealth Corp is measured differently than its book value, which is the value of DarioHealth that is recorded on the company's balance sheet. Investors also form their own opinion of DarioHealth Corp's value that differs from its market value or its book value, called intrinsic value, which is DarioHealth Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DarioHealth Corp's market value can be influenced by many factors that don't directly affect DarioHealth Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DarioHealth Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if DarioHealth Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DarioHealth Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.